Waters Corporation Common Stock (WAT)
Stock · NYSE · Industrials
$414.69as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$372.57
Industry
Biotechnology: Laboratory Analytical Instruments
Fundamentals
- Market cap
- $36.79B
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
How Waters Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 23, 2026 · via SEC EDGAR / Finnhub
Waters Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- WATWaters Corporation Common Stock$414.69▼ 1.56%Market cap $36.79BP/E —
- AAgilent Technologies Inc. Common Stock$153.84▼ 2.44%Market cap $39.48BP/E 29.37$108.35$163.75
- RVTYRevvity Inc. Common Stock$128.8▼ 0.70%Market cap $12.85BP/E 55.10$81.22$129.8
- TXG10x Genomics Inc. Class A Common Stock$61.55▼ 5.10%Market cap $5.97BP/E —$11.16$66.94
- EYPTEyePoint Inc. Common Stock$4.47▼ 3.46%Market cap $1.04BP/E —$3.95$19.11
- CTKBCytek Biosciences Inc. Common Stock$4.69▲ 1.41%Market cap $556.60MP/E —$3.28$6.18
- PACBPacific Biosciences of California Inc. Common Stock$1.4▼ 10.00%Market cap $441.05MP/E —$1.07$2.73
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| WAT Waters Corporation Common Stock | $36.79B | — | $414.69 | ▼ 1.56% | |
| A Agilent Technologies Inc. Common Stock | $39.48B | 29.37 | $153.84 | ▼ 2.44% | $108.35$163.75 |
| RVTY Revvity Inc. Common Stock | $12.85B | 55.10 | $128.8 | ▼ 0.70% | $81.22$129.8 |
| TXG 10x Genomics Inc. Class A Common Stock | $5.97B | — | $61.55 | ▼ 5.10% | $11.16$66.94 |
| EYPT EyePoint Inc. Common Stock | $1.04B | — | $4.47 | ▼ 3.46% | $3.95$19.11 |
| CTKB Cytek Biosciences Inc. Common Stock | $556.60M | — | $4.69 | ▲ 1.41% | $3.28$6.18 |
| PACB Pacific Biosciences of California Inc. Common Stock | $441.05M | — | $1.4 | ▼ 10.00% | $1.07$2.73 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Agilent Stock Has A Catalyst Coming On August 26 That Investors Should Not IgnoreYahoo · 8/21/2026
- 1 Unpopular Stock That Deserves a Second Chance and 2 That UnderwhelmYahoo · 8/18/2026
- Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The UpsideSeekingAlpha · 8/16/2026
- The 5 Most Interesting Analyst Questions From Waters Corporation’s Q2 Earnings CallYahoo · 8/13/2026
- Waters (WAT) Q2 2026 Earnings Call TranscriptYahoo · 8/11/2026
- 1 Surging Stock with Competitive Advantages and 2 We Turn DownYahoo · 8/10/2026
- Citigroup Maintains Buy on Waters, Raises Price Target to $470Benzinga · 8/10/2026
- Waters Q2 Earnings Call HighlightsYahoo · 8/9/2026
Insider Activity
Insider Actions →Acquired
1.8K
Disposed
5.3K
- Heather Knight · June 30, 2026 · Grant63
- Wei Jiang · June 30, 2026 · Grant67
- Robert L. Carpio III · June 24, 2026 · Tax Withholding189 @ $369.18
- Amol Chaubal · May 12, 2026 · Tax Withholding239 @ $352.21
- Jianqing Bennett · April 6, 2026 · Tax Withholding302 @ $304.09
- Wei Jiang · March 31, 2026 · Grant64
- Heather Knight · March 31, 2026 · Grant68
- Wei Jiang · March 16, 2026 · Buy500 @ $289.46
- Richard H. Fearon · March 6, 2026 · Buy1.0K @ $306.34
- Udit Batra · March 2, 2026 · Tax Withholding3.4K @ $307.23
- Amol Chaubal · March 2, 2026 · Tax Withholding709 @ $307.23
- Jianqing Bennett · March 2, 2026 · Tax Withholding410 @ $307.23
Institutional Ownership
March 31, 2026
- Total shares held
- 87.44M
- Total value held
- $24.57B
- Institutional holders
- 1158
Top holders this quarter
- Unknown8.54M
- Unknown6.38M
- Unknown4.66M
- Unknown4.63M
- Unknown4.36M
- Unknown3.21M
- Unknown2.65M
- Unknown2.17M
- Unknown2.12M
- Unknown1.64M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedSynthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
August 30, 2026
Piper Sandler Upgrades Waters to Overweight, Lifts Price Target. Piper Sandler upgraded Waters Corporation to Overweight, raising its price target to $480. The move was highlighted among several top upgrades of the day, with the analyst turning more positive on the stock. Separately, a retrospective noted how a $1,000 investment in Waters 20 years ago would have grown significantly. The stock trades well above its 52-week low of $278.49, with RSI near 60 indicating recent upward momentum.